N‐acetylcysteine as a treatment for substance use cravings: A meta‐analysis
Addiction Biology · 2024-11 · 29 (11)
DOI: 10.1111/adb.70001 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Addiction Biology, online erschienen am 18.11.2024. Verfasst von Emma L Winterlind und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Acetylcysteine, Craving, Substance-Related Disorders. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAAA NIH HHS, Department of Defense, National Institute on Alcohol Abuse and Alcoholism.
Abstract (Originalsprache)
N‐acetylcysteine (NAC) may serve as a novel pharmacotherapy for substance use and substance craving in individuals with substance use disorders (SUDs), possibly through its potential to regulate glutamate. Though prior meta‐analyses generally support NAC's efficacy in reducing symptoms of craving, individual trials have found mixed results. The aims of this updated meta‐analysis were to (1) examine the efficacy of NAC in treating symptoms of craving in individuals with SUD and (2) explore subgroup differences, risk of bias and publication bias across trials. Database searches of PubMed, Cochrane Library and ClinicalTrials.gov were conducted in June and July of 2023 to identify relevant randomized control trials (RCTs). The meta‐analysis consisted of 9 trials which analysed data from a total of 623 participants. The most targeted substance in the clinical trials was alcohol (3/9; 33.3%), followed by tobacco (2/9; 22.2%) and multiple substances (2/9; 22.2%). Meta‐analysis, subgroup analyses and leave‐one‐out analyses were conducted to examine the treatment effect on craving symptoms and adverse events (AEs). Risk of bias assessments, Egger's tests and funnel plot tests were conducted to examine the risk of bias and publication bias. NAC did not significantly outperform placebo in reducing symptoms of craving in the meta‐analysis (SMD = 0.189, 95% CI = −0.015–0.393). Heterogeneity was very high in the meta‐analysis (99.26%), indicating that findings may have been influenced by clinical or methodological differences in the study protocols. Additionally, results indicate that there may be publication bias present. Overall, our findings are contrary to those of prior meta‐analyses, suggesting a limited impact of NAC on substance craving. However, the high heterogeneity and presence of publication bias identified warrants cautious interpretation of the meta‐analytic outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
- Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, Maryland, USA.
- Department of Psychology, University of Wyoming, Laramie, Wyoming, USA.
- Department of Psychology, Fordham University, Bronx, New York, USA.
- Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
ORCID-Profile: Emma L Winterlind, Joshua C Gray
Förderung
- NIAAA NIH HHS
- Department of Defense
- National Institute on Alcohol Abuse and Alcoholism
- U.S. Department of Defense
Zitieren
APA
Winterlind, E. L., Malone, S. G., Setzer, M. R., Murphy, M. A., Saunders, D., & Gray, J. C. (2024). N‐acetylcysteine as a treatment for substance use cravings: A meta‐analysis. Addiction Biology, 29(11). https://doi.org/10.1111/adb.70001
Vancouver
Winterlind EL, Malone SG, Setzer MR, Murphy MA, Saunders D, Gray JC. N‐acetylcysteine as a treatment for substance use cravings: A meta‐analysis. Addiction Biology. 2024;29(11). doi:10.1111/adb.70001
BibTeX
@article{Winterlind2024,
author = {Winterlind, Emma L and Malone, Samantha G and Setzer, Michael R and Murphy, Mikela A and Saunders, David and Gray, Joshua C},
title = {N‐acetylcysteine as a treatment for substance use cravings: A meta‐analysis},
journal = {Addiction Biology},
year = {2024},
volume = {29},
number = {11},
doi = {10.1111/adb.70001}
}
EUVIMED